Primary care investor Assura has posted a portfolio value of £2bn for the six months ending 30 September, mainly driven by acquisitions and new developments.
The company’s investments now cover 560 medical centres, alongside pipelines of £65m for targeted acquisitions and £72m for developments.
Diluted EPRA NAV per share inched up to 53.5p in the six months ending September, compared with 53.3p in March.
Profit before tax was down by 2.7% to £36.4m on the previous year, on the back of lower revaluation gains.
Net rental income was up by 9.5% to £50.6m compared with the same period in 2018, while the annual rent roll increased by 1.7% to £104.4m.
Loan-to-value ratio inched up by 2% to 36%, compared with the previous half-year period ending March.
Chief executive Jonathan Murphy said: “Assura has today delivered another strong performance, driven by new developments and carefully selected acquisitions.
“Our pipeline is the strongest it has been in 10 years, enhanced by the acquisition of GPI, which has created fresh opportunities for Assura.
“The UK’s primary care infrastructure continues to be in immediate need of modernisation, which would ease the significant strain on NHS services.”
To send feedback, e-mail pui-guan.man@egi.co.uk or tweet @PuiGuanM or @estatesgazette
